DOI: https://doi.org/10.24061/1727-4338.XIII.3.49.2014.46

ПАТОБІОХІМІЧНІ ТА ПАТОМОРФОЛОГІЧНІ ЕКВІВАЛЕНТИ УРАЖЕННЯ ПАРОДОНТА ТА СЛИЗОВОЇ ОБОЛОНКИ РОТОВОЇ ПОРОЖНИНИ ПРИ ЦУКРОВОМУ ДІАБЕТІ

O. V. Tkachuk, A. A. Galagdina, S. S. Tkachuk, V. F. Myslytskyi

Анотація


Резюме. Проаналізовано сучасні дані стосовно механізмів ураження пародонта та слизової оболонки ротової порожнини у хворих на цукровий діабет.


Ключові слова


цукровий діабет; пародонт; слизова оболонка ротової порожнини

Повний текст:

PDF

Посилання


Balakhonov LV, Aydagulova CB, Nepomnyashchikh LM. Kliniko-patomorfologicheskoe issledovanie diabeticheskoy parodontopatii u bol'nykh sakharnym diabetom [Clinical and pathological study of diabetic periodontal disease in patients with diabetes. Siberian Journal of Gastroenterology Hepatology]. Sibirskiy zhurnal gastroenterologii gepatologii. 2005;19:136-37. (in Russian).

Balakhonov LV, Nepomnyashchikh LM, Aydagulova CB, Bakarev MA, Vlasova LF. Strukturnye reaktsii slizistoy obolochki polosti rta pri diabeticheskoy parodontopatii [Structural reactions of the oral mucosa with diabetic periodontal disease.]. Byulleten' eksperimental'noy biologii i meditsiny. 2006;11(142): 581-84. (in Russian).

Saini R, Al-Maweri SA, Saini D, Ismail NM, Ismail AR. Oral mucosal lesions in non oral habit diabetic patients and association of diabetes mellitus with oral precancerous lesions. Diabetes Res Clin Pract. 2010 Sep;89(3):320-6. doi: 10.1016/j.diabres.2010.04.016.

Lamster IB, Lalla E, Borgnakke WS, Taylor GW. The relationship between oral health and diabetes mellitus. J Am Dent Assoc. 2008 Oct;139 Suppl:19S-24S.

Stegeman CA. Oral manifestations of diabetes. Home Health Nurse. 2005;23(4):233-40.

Preshaw PM. Diabetes and periodontal disease. J Dent. 2009 Aug;37(8):S575-7. doi: 10.1016/j.jdent.2009.05.019

Bastos AS, Leite AR, Spin-Neto R, Nassar PO, Massucato EM, Orrico SR. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract. 2011 Apr;92(1):100-5. doi: 10.1016/j.diabres.2011.01.011.

Radhika T, Kannan R. Diabetes mellitus and oral health. J Orofac Sci. 2012;4(1): 7-10.

Taylor GW, Borgnakke WS. Periodontal disease: associations with diabetes, glycemic control and complications. Special Review in Periodontal Medicine. Oral Dis. 2008 Apr;14(3):191-203. doi: 10.1111/j.1601-0825.2008.01442.x.

Straka M. Oral manifestations of diabetes mellitus and influences of periodontological treatment on diabetes mellitus. Bratisl Lek Listy. 2011;112(7):416-20.

Gursoy UK, Marakoglu I, Ersan S. Periodontal status and cytoplasmic enzyme activities in gingival crevicular fluid of type 2 diabetic and/or obese patients with chronic periodontitis. J Int Acad Periodontol. 2006 Jan;8(1):2-5.

Kardeşler L, Biyikoğlu B, Cetinkalp S. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics. Oral Dis. 2010;16(5):476-81.

Ikekpeazu EJ, Neboh EE, Maduka IC, Anyanwu EG, Okenyi NS. Periodontal disease and type 2 diabetes: Effects on salivary enzyme activities. Int J Diabetes Dev Ctries. 2011;31(1):9-13.

Chen L, Wei B, Li J, Liu F, Xuan D, Xie B, et al. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes. J Periodontol. 2010 Mar;81(3):364-71. doi: 10.1902/jop.2009.090544.

Sashikumar R, Kannan R. Salivary glucose levels and oral candida carriage in type II diabetics. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):706-11. doi: 10.1016/j.tripleo.2009.12.042.

Scardina GA, Cacioppo A, Messina P. Periodontal microcirculation in diabetics: an in vivo non-invasive analysis by means of videocapillaroscopy. Med Sci Monit. 2012 Feb;18(2):CR58-64.

Liang W, Tan CY, Ang L, Sallam N, Granville DJ, Wright JM, et al. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice. J Physiol Sci. 2008 Dec;58(6):405-11. doi: 10.2170/physiolsci.RP012808.

Hanes PJ, Krishna R. Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible? EPMA J. 2010 Mar;1(1):101-16. doi: 10.1007/s13167-010-0016-3.

Motta-Silva AC, Aleva NA, Chavasco JK, Armond MC, França JP, Pereira LJ. Erythematous Oral Candidiasis in Patients with Controlled Type II Diabetes Mellitus and Complete Dentures. Mycopathologia. 2010 Mar;169(3):215-23. doi: 10.1007/s11046-009-9240-6.

Pradeep AR, Daisy H, Hadge P, Garg G, Thorat M. Correlation of gingival crevicular fluid interleukin-18 and monocyte hemoattractant protein-1 levels in periodontal health and disease. J Periodontol. 2009 Sep;80(9):1454-61. doi: 10.1902/jop.2009.090117.

Andriankaja OM, Barros SP, Moss K, Panagakos FS, DeVizio W, Beck J, et al. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1β and prostaglandin E2 among non-smoking subjects with gingivitis and type 2 diabetes. J Periodontol. 2009 Feb;80(2):307-16. doi: 10.1902/jop.2009.080385.

Javed F, Al-Askar M, Al-Hezaimi K. Cytokine profile in the gingival crevicular fluid of periodontitis patients with and without type 2 diabetes: a literature review. J Periodontol. 2012 Feb;83(2):156-61. doi: 10.1902/jop.2011.110207.

Field CA, Gidley MD, Preshaw PM, Jakubovics N. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes. J Periodontal Res. 2012 Aug;47(4):470-8. doi: 10.1111/j.1600-0765.2011.01455.x.

24. Becerik S, Afacan B, Oztürk VÖ, Atmaca H, Emingil G. Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-terminal telopeptid levels in health and different periodontal diseases. Dis Markers. 2011;31(6):343-52. doi: 10.3233/DMA-2011-0849.

Li X, Zhang L, Wang N, Feng X, Bi L. Periodontal ligament remodeling and alveolar bone resorption during orthodontic tooth movement in rats with diabetes. Diabetes Technol Ther. 2010 Jan;12(1):65-73. doi: 10.1089/dia.2009.0085.

Yamamoto TT. Orthodontic tooth movement and expression of calcium regulating hormone. Clin Calcium. 2012 Jan;22(1):91-8. doi: CliCa12019198.

Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q, et al Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006 Jun;85(6):510-4. 10.1177/154405910608500606.

Desta T, Li J, Chino T, Graves DT. Altered fibroblast proliferation and apoptosis in diabetic gingival wounds. J Dent Res. 2010 Jun;89(6):609-14. doi: 10.1177/0022034510362960.

Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, Faibish D,et al. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res. 2010 Jul;25(7):1604-15. doi: 10.1002/jbmr.59.

Tan KC, Chow WS, Tam S, Bucala R, Betteridge J. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care. 2004 Jan;27(1):223-8.

King G.L. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008 Aug;79(8 Suppl):1527-34. doi: 10.1902/jop.2008.080246.

Abebe W, Mozaffari M. Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools. EPMA J. 2010 Mar;1(1):32-45. doi: 10.1007/s13167-010-0012-7.

Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis: Impact on periodontal pathology. J Dent Res. 2006 Jan;85(1):15-21. doi: 10.1177/154405910608500103.

Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res. 2010 Mar 19;106(5):842-53. doi: 10.1161/CIRCRESAHA.109.212217.

Ding H, Triggle CR. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium. Vasc Health Risk Manag. 2005;1(1):55-71.

Yang J, Park Y, Zhang H, Gao X, Wilson E, Zimmer W, et al. Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1208-16. doi: 10.1152/ajpheart.00396.2009.

Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):135-41. doi: 10.1097/MED.0b013e3282f824b7.

Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011 Jun 28;7(12):738-48. doi: 10.1038/nrendo.2011.106.

Yoshimura A, Kaneko T, Kato Y, Golenbock DT, Hara Y. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4. Infect Immun. 2002 Jan;70(1):218-25.

Ogawa T, Asai Y, Hashimoto M, Takeuchi O, Kurita T, Yoshikai Y, et al. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. Int Immunol. 2002 Nov;14(11):1325-32.

Check J, Byrd CL, Menio J, Rippe RA, Hines IN, Wheeler MD. Src kinase participates in LPS-induced activation of NADPH oxidase. Mol Immunol. 2010 Jan;47(4):756-62. doi: 10.1016/j.molimm.2009.10.012.

Black P. The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun. 2003 Oct;17(5):350-64.

Streja D, Cressey P, Rabkin SW. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003 May-Jun;17(3):120-7.

Prapulla DV, Sujatha PB, Pradeep AR. Gingival Crevicular Fluid VEGF Levels in Periodontal Health and Disease. J Periodontol. 2007 Sep;78(9):1783-7. doi: 10.1902/jop.2007.070009.

Sakallioğlu EE, Aliyev E, Lütfioğlu M, Yavuz U, Açikgöz G. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig. 2007 Jun;11(2):115-20. doi: 10.1007/s00784-006-0097-5.

Unlü F, Güneri PG, Hekimgil M, Yeşilbek B, Boyacioğlu H. Expression of vascular endothelial growth factor in human periodontal tissues: comparison of healthy and diabetic patients. J Periodontol. 2003 Feb;74(2):181-7. doi: 10.1902/jop.2003.74.2.181.

Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci. 2006 Nov;47(11):5106-15. doi: 10.1167/iovs.06-0322.

Güneri P, Unlü F, Yeşilbek B, Bayraktar F, Kokuludağ A, Hekimgil M, et al. Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. J Periodontol. 2004 Jan;75(1):91-7. doi: 10.1902/jop.2004.75.1.91.

Pradhan S, Goel K. Interrelationship between diabetes and periodontitis: a review. JNMA J Nepal Med Assoc. 2011 Jul-Sep;51(183):144-53.

Darré L, Vergnes JN, Gourdy P, Sixou M. Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studies. Diabetes Metab. 2008 Nov;34(5):497-506. doi: 10.1016/j.diabet.2008.03.006.


Пристатейна бібліографія ГОСТ


1. Балахонов Л.В. Клинико-патоморфологическое исследование диабетической пародонтопатии у больных сахарным диабетом / Л.В. Балахонов, C.B. Айдагулова, Л.М. Непомнящих // Сиб. журн. гастроэнтерол. гепатол. – 2005. – № 19. – С. 136–137.

2. Структурные реакции слизистой оболочки полости рта при диабетической пародонтопатии / Л.В. Балахонов, Л.М. Непомнящих, C.B. Айдагулова [и др.] // Бюл. эксперим. биол. и мед. – 2006. – Т.142, №11. – С. 581–584.

3. Oral mucosal lesions in non oral habit diabetic patients and association of diabetes mellitus with oral precancerous lesions / R. Sainia, S. Ali Al-Maweria, D. Sainib [et al.] // Diabetes Res.Clin. Practice.– 2010.–Vol. 89, Iss.3.– P. 320-326.

4. The relationship between oral health and diabetes mellitus / I.B. Lamster, E. Lalla, W.S. Borgnakke, G.W. Taylor // J. Am. Dent. Assoc. – 2008. – Vol.139, Suppl. – Р. 19–24.

5. Siegeman C.A. Oral manifestations of diabetes / C.A. Siegeman // Home Health Nurse. – 2005. – Vol. 23, № 4. – P. 233–240.

6. Preshaw P.M. Diabetes and periodontal disease / P.M. Preshaw // Intern. Dental J. – 2008. – Vol.58, Iss.S4. – Р. 237–243.

7. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors / A.S. Bastosa, A.R. Leite, R. Spin-Netoa [et al.] // Diabetes Res. Clin. Pract. – 2011. – Vol.92, №1. – Р. 100–105.

8. Radhika T. Diabetes mellitus and oral health / T. Radhika, R. Kannan // J. Orofac. Sci. – 2012. – Vol. 4, Iss. 1. – P. 7–10.

9. Taylor G.W. Periodontal disease: associations with diabetes, glycemic control and complications. Special Review in Periodontal Medicine / G.W. Taylor, W.S. Borgnakke // Oral Diseases. – 2008. – Vol.14, №3. – P. 191–203.

10. Straka M. Oral manifestations of diabetes mellitus and influences of periodontological treatment on diabetes mellitus / M. Straka // Bratisl. Lek. Listy. –2011– Vol.112, №7. – Р. 416–420.

11. Gursoy U.K. Periodontal status and cytoplasmic enzyme activities in gingival crevicular fluid of type 2 diabetic and/or obese patients with chronic periodontitis / U.K. Gursoy, I. Marakoglu, S. Ersan // J. Int. Acad. Periodontol. – 2006. – Vol.8, №1. – Р. 2–5.

12. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics / L. Kardeşler, B.Biyikoğlu, S. Cetinkalp [et al.] // Oral Dis. – 2010. – Vol.16, №5. – Р. 476–481.

13. Periodontal disease and type 2 diabetes: Effects on salivary enzyme activities / E.J. Ikekpeazu, E.E. Neboh, I.C. Maduka [et al.] // Int. J. Diabetes Dev. Ctries. – 2011. – Vol.31, №1. – Р. 9–13.

14. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes / L. Chen, B.Wei, J. Li [et al.] // J. Periodontol. – 2010.– Vol. 81, №3. – Р. 364–371.

15. Sashikumar R. Salivary glucose levels and oral candida carriage in type II diabetics / R. Sashikumar, R. Kannan // Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. – 2010. – Vol.109, №5. – Р. 706–711.

16. Scardina G.A. Periodontal microcirculation in diabetics: an in vivo non-invasive analysis by means of videocapillaroscopy / G.A. Scardina, A. Cacioppo, P. Messina // Med. Sci. Monit. – 2012. –Vol.18, №2. – Р. 58–64.

17. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice / W. Liang, Y. Tan C., L. Ang, N. Sallam // J. Physiol Sci. – 2008. – Vol.58, №6. – Р. 405–511.

18. Hanes P. J. Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible? / P. J. Hanes, R. Krishna // EPMA J. – 2010. – Vol.1, №1.– Р. 101–116.

19. Erythematous Oral Candidiasis in Patients with Controlled Type II Diabetes Mellitus and Complete Dentures / C. M.-S. Arlindo, A. A. Natanael, K. C. Jorge [et al.] // Mycopathologia. – 2010. – Vol.169, №3. – Р. 215–223.

20. Correlation of gingival crevicular fluid interleukin-18 and monocyte hemoattractant protein-1 levels in periodontal health and disease / A.R. Pradeep, H. Daisy, P. Hadge, G. Garg // J. Periodontol.–2009. – Vol.80,№9.– Р. 1454–1461.

21. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1β and prostaglandin E2 among non-smoking subjects with gingivitis and type 2 diabetes / O. Andriankaja, S. Barros, K. Moss [et al.] // J. Periodontol. – 2009. – Vol.80, №2. – Р. 307–316.

22. Cytokine profile in the gingival crevicular fluid of periodontitis patients with and without type 2 diabetes: a literature review / F. Javed, M. Al-Askar, K. Al-Hezaimi [et al.] // J. Periodontol.– 2012. – Vol.83, №2. – Р. 156-161.

23. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes / C.A. Field, M.D. Gidley, P.M. Preshaw, N. Jakubovics // J. Periodontal Res. – 2012. – Vol.47, №4. – Р. 470–478.

24. Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-terminal telopeptid levels in health and different periodontal diseases / S. Becerik, B.Afacan, V.Ö. Oztürk, H. Atmaca // Dis. Markers. – 2011. – Vol.31, №6. – Р. 343–352.

25. Periodontal ligament remodeling and alveolar bone resorption during orthodontic tooth movement in rats with diabetes / X. Li, L. Zhang, N. Wang [et al.] // Diabetes Technol. Ther. – 2010. – Vol.12, №1. – Р.65–73.

26. Yamamoto T.T. Orthodontic tooth movement and expression of calcium regulating hormone / T.T. Yamamoto // Clin. Calcium.–2012.–Vol.22,№1.– Р. 91-98.

27. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation / R. Liu, H. Bal, T. Desta [et al] // J. Dent. Res. – 2006. – Vol.85, №6. – Р. 510–514.

28. Altered fibroblast proliferation and apoptosis in diabetic gingival wounds / T. Desta, J. Li, T. Chino, D.T. Graves // J. Dent. Res. – 2010. – Vol.89, №6. – Р. 609–614.

29. TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1 // R.A. Kayal, M.Siqueira, J. Alblowi [et al.] // J. Bone Miner. Res. – 2010. – Vol.25, №7. – Р. 1604-1615.

30. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes / K. Tan, W. Chow, S. Tam [et al.] // Diabetes Care. – 2004. – Vol.27, №1. – Р. 223–228.

31. King G.L. The role of inflammatory cytokines in diabetes and its complications / G.L. King // J. Periodontol.– 2008.– Vol.79, Suppl 8. – Р. 1527–1534.

32. Abebe W. Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools / W. Abebe, M. Mozaffari // EPMA J. – 2010. – Vol.1, №1. – Р. 32–45.

33. Diabetes-enhanced inflammation and apoptosis: Impact on periodontal pathology / D.T. Graves, R. Liu, M. Alikhani [et al.] // J. Dent. Res. – 2006. – Vol.85, №1. – Р. 15–21.

34. Yan S.F. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature / S.F. Yan, R. Ramasamy, A.M. Schmidt // Circ. Res. –2010. – Vol.106, №5. – Р. 842–853.

35. Ding H. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium / H. Ding, C.R. Triggle // Vasc. Health Risk Manag. – 2005. – Vol.1, №1. – Р. 55–71.

36. Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice / J. Yang, Y. Park, H. Zhang [et al.] // Am. J. Physiol. Heart Circ. Physiol.– 2009. – Vol.297, №4. – Р. 1208–1216.

37. Mealey S.L. Diabetes mellitus and inflammatory periodontal disease. Current opinion in endocrinology / S.L. Mealey, L.F. Fose // Curr. Opin. Endocrinol. Diabetes Obes. – 2008. – Vol.15, Iss.2. – P. 135–141.

38. Lalla E. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases / E. Lalla, P.N. Papapanou // Nat. Rev. Endocrinol. – 2011. – Vol.7, №12. – Р. 738–748.

39. Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human Toll-like receptor 4 / A. Yoshimura, T. Kaneko, Y. Kato [et al.] // Infect. Immun. – 2002. – Vol.70, №1. – Р. 218–225.

40. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway / T. Ogawa, Y. Asai, M. Hashimoto [et al.] // Int. Immunol. – 2002. – Vol.14, №1. – Р. 1325–1332.

41. Src kinase participates in LPS-induced activation of NADPH oxidase / J. Check, C.L.Byrd, J. Menio [et al.] // Moll. Immunol. – 2010. – Vol.47, №4. – Р. 756–762.

42. Black P. The inflammatory response in an integral part of the stress response: implications for atherosclerosis, insulin resistance, type 2 diabetes and metabolic syndrome / P. Black // Behav. Immun. – 2003. – Vol.17, №5. – Р.350–364.

43. Streja D. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus / D. Streja, P. Cressey, S. Rabkin // J. Diabetes Complications. – 2003. – Vol.17, №3. – Р.120–127.

44. Prapulla D. Gingival Crevicular Fluid VEGF Levels in Periodontal Health and Disease / D. Prapulla, P. Sujatha, A. Pradeep // J. Periodontol. – 2007. – Vol.78, №9. – Р. 1783–1787.

45. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients / E. Sakallioğlu, E.Aliyev, M. Lütfioğlu [et al.] // Clin. Oral Investig. – 2007. – Vol.11, №2. – Р. 115–120.

46. Expression of vascular endothelial growth factor in human periodontal tissues: comparison of healthy and diabetic patients / F. Unlu, G. P. Gurdal, M. Hekimgil [et al.] // J. Periodontol. – 2003. – Vol.74, №7. – Р.181–187.

47. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability / N.S. Harhaj, E.A. Felinski, E.B. Wolpert [et al.] // Invest. Ophthalmol. Visual Sci. – 2006. – Vol.47, №11. – Р. 5106–5115.

48. Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients / P. Güneri, F. Ünlü, B. Yeşilbek [et al.] // J. Periodontol. – 2004. – Vol.75, №1. – Р. 91–97.

49. Pradhan S. Interrelationship between diabetes and periodontitis: a review / S. Pradhan, K. Goel // J. Nepal. Med. Assoc. – 2011.– Vol.51, №183.– Р. 144–153.

50. Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studies / L. Darr, J.N. Vergnes, P. Gourdy, M. Sixou // Diabetes Metab. – 2008. – Vol.34, №5. – Р. 497–506.





© Clinical & Experimental Pathology, 2004-2019
When you copy an active link to the material is required
ISSN 2521-1153 (Online)
ISSN 1727-4338 (Print)
tel./fax +38(0372)553754